Projecting future drug expenditures in U.S. Nonfederal hospitals and clinics-2013

James M. Hoffman, Edward Li, Fred Doloresco, Linda Matusiak, Robert J. Hunkler, Nilay D. Shah, Lee C. Vermeulen, Glen T. Schumock

Research output: Contribution to journalArticle

14 Scopus citations

Abstract

Purpose. Factors likely to influence drug expenditures, drug expenditure trends in 2012, and projected drug expenditures for U.S. nonfederal hospitals and clinics in 2013 are discussed. Methods. Prescription drug expenditure data for 2011 through September 2012 were obtained from the IMS Health National Sales Perspectives database. Expenditure projections were based on a combination of quantitative and qualitative analyses, combined with expert opinion. Results. Total prescription sales in the United States for the 12-month period ending September 2012 were $326.0 billion, a 0.8% increase from the previous 12 months. This rate of growth was the lowest in recent history and can be attributed to modest increases in expenditures for new products (3.3%) and the prices of existing products (5.9%), coupled with a marked decline in overall volume and mix (-8.4%). For the 9 months ending in September 2012, total prescription expenditures grew 2.7% when compared with the same period in 2011. Oncology products remained important expenditures for hospitals and clinics. Antineoplastic agents were the top medication class for expenditures in nonfederal hospitals, and oncology products accounted for 32.2% of drug expenditures in the clinic setting in the first 9 months of 2012. Conclusion. For 2013, we project a 1-3% increase in total drug expenditures across all settings, a 2-4% increase in expenditures for clinic-administered drugs, and a 0.5% decline to 1.5% increase in hospital drug expenditures. Health-system pharmacy leaders should carefully examine their own local drug-utilization patterns to determine their own organization's drug expenditure forecast.

Original languageEnglish (US)
Pages (from-to)525-539
Number of pages15
JournalAmerican Journal of Health-System Pharmacy
Volume70
Issue number6
DOIs
StatePublished - Mar 15 2013

ASJC Scopus subject areas

  • Pharmacology
  • Health Policy

Fingerprint Dive into the research topics of 'Projecting future drug expenditures in U.S. Nonfederal hospitals and clinics-2013'. Together they form a unique fingerprint.

  • Cite this

    Hoffman, J. M., Li, E., Doloresco, F., Matusiak, L., Hunkler, R. J., Shah, N. D., Vermeulen, L. C., & Schumock, G. T. (2013). Projecting future drug expenditures in U.S. Nonfederal hospitals and clinics-2013. American Journal of Health-System Pharmacy, 70(6), 525-539. https://doi.org/10.2146/ajhp120759